Giuseppe Minniti: Another Dogma is Disappearing for SCLC Brain Metastases
Giuseppe Minniti, Radiation Oncologist at Sapienza University of Rome, shared a post on X about a recent article by Ayal A. Aizer et al., published on Journal of Clinical Oncology.
“Another dogma is disappearing: SRS is effective for SCLC BM.
Stereotactic Radiosurgery in Patients With Small Cell Lung Cancer and 1-10 Brain Metastases: A Multi-Institutional, Phase II, Prospective Clinical Trial, Journal of Clinical Oncology.”
Title: Stereotactic Radiosurgery in Patients With Small Cell Lung Cancer and 1-10 Brain Metastases: A Multi-Institutional, Phase II, Prospective Clinical Trial
Authors: Ayal A. Aizer, Shyam K. Tanguturi, Diana D. Shi, Paul J. Catalano, Kee-Young Shin, Ivy Ricca, Marciana Johnson, Grant Benham, David E. Kozono, Raymond H. Mak, Lauren Hertan, Fallon Chipidza, Monica Krishnan, Itai Pashtan, Luke Peng, Jack M. Qian, Ron Y. Shiloh, Daniel N. Cagney, Jacob Sands, Paul D. Brown, Patrick Y. Wen, Daphne A. Haas-Kogan, Rifaquat Rahman
Read The Full Article at Journal of Clinical Oncology.
More Posts Featuring SCLC.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023